{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:49:34Z","timestamp":1793292574726,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41591-026-04246-4","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:02:56Z","timestamp":1770415376000},"page":"1444-1453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pulsed field ablation versus conventional thermal ablation for paroxysmal atrial fibrillation: 4-year outcomes in the ADVENT-LTO study"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5638-4993","authenticated-orcid":false,"given":"Vivek Y.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Gerstenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros E.","family":"Mountantonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Ellenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas N.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-5638","authenticated-orcid":false,"given":"Jonathan W.","family":"Waks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjaya K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Whang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Daccarett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Cuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Delurgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9251-6693","authenticated-orcid":false,"given":"Matthew D.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ADVENT-LTO Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"4246_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","volume":"83","author":"JA Joglar","year":"2024","unstructured":"Joglar, J. A. et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 83, 109\u2013279 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4246_CR2","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","volume":"14","author":"H Calkins","year":"2017","unstructured":"Calkins, H. et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 14, e275\u2013e444 (2017).","journal-title":"Heart Rhythm"},{"key":"4246_CR3","doi-asserted-by":"publisher","first-page":"107871","DOI":"10.1016\/j.bioelechem.2021.107871","volume":"141","author":"T Batista Napotnik","year":"2021","unstructured":"Batista Napotnik, T., Polajzer, T. & Miklavcic, D. Cell death due to electroporation\u2014a review. Bioelectrochemistry 141, 107871 (2021).","journal-title":"Bioelectrochemistry"},{"key":"4246_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/CIRCEP.113.001111","volume":"7","author":"VJ Van Driel","year":"2014","unstructured":"Van Driel, V. J. et al. Pulmonary vein stenosis after catheter ablation: electroporation versus radiofrequency. Circ. Arrhythm. Electrophysiol. 7, 734\u2013738 (2014).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"4246_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008337","volume":"13","author":"B Howard","year":"2020","unstructured":"Howard, B. et al. Reduction in pulmonary vein stenosis and collateral damage with pulsed field ablation compared with radiofrequency ablation in a canine model. Circ. Arrhythm. Electrophysiol. 13, e008337 (2020).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"4246_CR6","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.hrthm.2015.05.012","volume":"12","author":"VJ Van Driel","year":"2015","unstructured":"Van Driel, V. J. et al. Low vulnerability of the right phrenic nerve to electroporation ablation. Heart Rhythm 12, 1838\u20131844 (2015).","journal-title":"Heart Rhythm"},{"key":"4246_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.010127","volume":"15","author":"B Howard","year":"2022","unstructured":"Howard, B. et al. Characterization of phrenic nerve response to pulsed field ablation. Circ. Arrhythm. Electrophysiol. 15, e010127 (2022).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"4246_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004672","volume":"10","author":"K Neven","year":"2017","unstructured":"Neven, K. et al. Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagus. Circ. Arrhythm. Electrophysiol. 10, e004672 (2017).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"4246_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.007781","volume":"12","author":"JS Koruth","year":"2019","unstructured":"Koruth, J. S. et al. Preclinical evaluation of pulsed field ablation: electrophysiological and histological assessment of thoracic vein isolation. Circ. Arrhythm. Electrophysiol. 12, e007781 (2019).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"4246_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.008303","volume":"13","author":"JS Koruth","year":"2020","unstructured":"Koruth, J. S. et al. Pulsed field ablation versus radiofrequency ablation: esophageal injury in a novel porcine model. Circ. Arrhythm. Electrophysiol. 13, e008303 (2020).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"4246_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.06.033","author":"M Nies","year":"2025","unstructured":"Nies, M. et al. Is the esophagus spared during pulsed field ablation? Early histopathology and in vivo esophageal retraction. Heart Rhythm https:\/\/doi.org\/10.1016\/j.hrthm.2025.06.033 (2025).","journal-title":"Heart Rhythm"},{"key":"4246_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jacep.2018.04.005","volume":"4","author":"VY Reddy","year":"2018","unstructured":"Reddy, V. Y. et al. Ablation of atrial fibrillation with pulsed electric fields: an ultra-rapid, tissue-selective modality for cardiac ablation. JACC Clin. Electrophysiol. 4, 987\u2013995 (2018).","journal-title":"JACC Clin. Electrophysiol."},{"key":"4246_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jacc.2019.04.021","volume":"74","author":"VY Reddy","year":"2019","unstructured":"Reddy, V. Y. et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J. Am. Coll. Cardiol. 74, 315\u2013326 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4246_CR14","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/europace\/euab090","volume":"23","author":"H Cochet","year":"2021","unstructured":"Cochet, H. et al. Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation. Europace 23, 1391\u20131399 (2021).","journal-title":"Europace"},{"key":"4246_CR15","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/s41591-024-03114-3","volume":"30","author":"E Ekanem","year":"2024","unstructured":"Ekanem, E. et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat. Med. 30, 2020\u20132029 (2024).","journal-title":"Nat. Med."},{"key":"4246_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jacc.2025.10.051","volume":"87","author":"MK Turagam","year":"2026","unstructured":"Turagam, M. K. et al. Multicenter study on the safety of pulsed field ablation in over 40,000 patients: MANIFEST-US. J. Am. Coll. Cardiol. 87, 172\u2013193 (2026).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4246_CR17","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","volume":"389","author":"VY Reddy","year":"2023","unstructured":"Reddy, V. Y. et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N. Engl. J. Med. 389, 1660\u20131671 (2023).","journal-title":"N. Engl. J. Med."},{"key":"4246_CR18","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/s41591-024-03022-6","volume":"30","author":"E Anter","year":"2024","unstructured":"Anter, E. et al. Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial. Nat. Med. 30, 2303\u20132310 (2024).","journal-title":"Nat. Med."},{"key":"4246_CR19","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1056\/NEJMoa2502280","volume":"392","author":"T Reichlin","year":"2025","unstructured":"Reichlin, T. et al. Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation. N. Engl. J. Med. 392, 1497\u20131507 (2025).","journal-title":"N. Engl. J. Med."},{"key":"4246_CR20","doi-asserted-by":"publisher","unstructured":"Jais, P. et al. Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf1115 (2026).","DOI":"10.1093\/eurheartj\/ehaf1115"},{"key":"4246_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jacc.2024.05.001","volume":"84","author":"VY Reddy","year":"2024","unstructured":"Reddy, V. Y. et al. Pulsed field vs conventional thermal ablation for paroxysmal atrial fibrillation: recurrent atrial arrhythmia burden. J. Am. Coll. Cardiol. 84, 61\u201374 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4246_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.123.064959","volume":"148","author":"MK Turagam","year":"2023","unstructured":"Turagam, M. K. et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry. Circulation 148, 35\u201346 (2023).","journal-title":"Circulation"},{"key":"4246_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad185","volume":"25","author":"B Schmidt","year":"2023","unstructured":"Schmidt, B. et al. EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry. Europace 25, euad185 (2023).","journal-title":"Europace"},{"key":"4246_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/CIRCEP.113.000495","volume":"6","author":"E Pokushalov","year":"2013","unstructured":"Pokushalov, E. et al. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation. Circ. Arrhythm. Electrophysiol. 6, 754\u2013760 (2013).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"4246_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/europace\/euaa298","volume":"23","author":"KH Kuck","year":"2021","unstructured":"Kuck, K. H. et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace 23, 362\u2013369 (2021).","journal-title":"Europace"},{"key":"4246_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2212540","volume":"388","author":"JG Andrade","year":"2023","unstructured":"Andrade, J. G. et al. Progression of atrial fibrillation after cryoablation or drug therapy. N. Engl. J. Med. 388, 105\u2013116 (2023).","journal-title":"N. Engl. J. Med."},{"key":"4246_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/eurheartj\/ehad572","volume":"45","author":"JG Andrade","year":"2024","unstructured":"Andrade, J. G. et al. Atrial fibrillation progression after cryoablation vs. radiofrequency ablation: the CIRCA-DOSE trial. Eur. Heart J. 45, 510\u2013518 (2024).","journal-title":"Eur. Heart J."},{"key":"4246_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/eurheartj\/ehac692","volume":"44","author":"JG Andrade","year":"2023","unstructured":"Andrade, J. G. et al. Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study. Eur. Heart J. 44, 765\u2013776 (2023).","journal-title":"Eur. Heart J."},{"key":"4246_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.125.074485","volume":"152","author":"VY Reddy","year":"2025","unstructured":"Reddy, V. Y. et al. Pulsed field ablation of persistent atrial fibrillation with continuous electrocardiographic monitoring follow-up: ADVANTAGE AF Phase 2. Circulation 152, 27\u201340 (2025).","journal-title":"Circulation"},{"key":"4246_CR30","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","volume":"147","author":"A Verma","year":"2023","unstructured":"Verma, A. et al. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation 147, 1422\u20131432 (2023).","journal-title":"Circulation"},{"key":"4246_CR31","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.124.070333","volume":"150","author":"VY Reddy","year":"2024","unstructured":"Reddy, V. Y. et al. Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the AdmIRE pivotal trial. Circulation 150, 1174\u20131186 (2024).","journal-title":"Circulation"},{"key":"4246_CR32","doi-asserted-by":"publisher","unstructured":"Reddy, V. Y. et al. Pulsed-field ablation to enhance the durability of pulmonary vein isolation and treat paroxysmal atrial fibrillation. J. Am. Coll. Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2025.10.084 (2026).","DOI":"10.1016\/j.jacc.2025.10.084"},{"key":"4246_CR33","first-page":"1664","volume":"85","author":"VY Reddy","year":"2025","unstructured":"Reddy, V. Y. et al. Pulsed field ablation for persistent atrial fibrillation: 1-year results of ADVANTAGE AF. J. Am. Coll. Cardiol. 85, 1664\u20131678 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4246_CR34","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.jacep.2023.06.019","volume":"9","author":"DR Musikantow","year":"2023","unstructured":"Musikantow, D. R. et al. Long-term clinical outcomes of pulsed field ablation in the treatment of paroxysmal atrial fibrillation. JACC Clin. Electrophysiol. 9, 2001\u20132003 (2023).","journal-title":"JACC Clin. Electrophysiol."},{"key":"4246_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ahj.2013.04.015","volume":"166","author":"P Dorian","year":"2013","unstructured":"Dorian, P. et al. Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful? Am. Heart J. 166, 381\u2013387 (2013).","journal-title":"Am. Heart J."},{"key":"4246_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.005358","volume":"12","author":"DN Holmes","year":"2019","unstructured":"Holmes, D. N. et al. Defining clinically important difference in the atrial fibrillation effect on quality-of-life score. Circ. Cardiovasc. Qual. Outcomes 12, e005358 (2019).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"4246_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jacep.2022.10.028","volume":"9","author":"DR Musikantow","year":"2023","unstructured":"Musikantow, D. R. et al. Pulsed field ablation to treat atrial fibrillation autonomic nervous system effects. JACC Clin. Electrophysiol. 9, 481\u2013493 (2023).","journal-title":"JACC Clin. Electrophysiol."},{"key":"4246_CR38","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jacep.2022.04.017","volume":"8","author":"P Stojadinovi\u0107","year":"2022","unstructured":"Stojadinovi\u0107, P. et al. Autonomic changes are more durable after radiofrequency than pulsed electric field pulmonary vein ablation. JACC Clin. Electrophysiol. 8, 895\u2013904 (2022).","journal-title":"JACC Clin. Electrophysiol."},{"key":"4246_CR39","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jacep.2024.05.005","volume":"10","author":"EP Gerstenfeld","year":"2024","unstructured":"Gerstenfeld, E. P. et al. Autonomic effects of pulsed field vs thermal ablation for treating atrial fibrillation: subanalysis of ADVENT. JACC Clin. Electrophysiol. 10, 1634\u20131644 (2024).","journal-title":"JACC Clin. Electrophysiol."},{"key":"4246_CR40","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/01.CIR.101.14.1736","volume":"101","author":"GW Taylor","year":"2000","unstructured":"Taylor, G. W. et al. Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs. Circulation 101, 1736\u20131742 (2000).","journal-title":"Circulation"},{"key":"4246_CR41","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/europace\/euab155","volume":"3","author":"Y Nakatani","year":"2021","unstructured":"Nakatani, Y. et al. Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation. Europace 3, 1767\u20131776 (2021).","journal-title":"Europace"},{"key":"4246_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.hroo.2023.03.001","volume":"4","author":"VY Reddy","year":"2023","unstructured":"Reddy, V. Y. et al. A randomized controlled trial of pulsed field ablation versus standard-of-care ablation for paroxysmal atrial fibrillation: the ADVENT trial rationale and design. Heart Rhythm O2 4, 317\u2013328 (2023).","journal-title":"Heart Rhythm O2"},{"key":"4246_CR43","doi-asserted-by":"publisher","first-page":"e318","DOI":"10.1016\/j.hrthm.2025.03.161","volume":"22","author":"SE Mountantonakis","year":"2025","unstructured":"Mountantonakis, S. E. et al. Predictors of atrial fibrillation freedom postablation with the pentaspline pulsed field ablation catheter: subanalysis of the ADVENT study. Heart Rhythm 22, e318\u2013e327 (2025).","journal-title":"Heart Rhythm"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04246-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:02:09Z","timestamp":1776780129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4246"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04246-4","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.Y.R. has served as a consultant to and received equity from Farapulse (now divested) and receives grant support from and serves as a consultant to Boston Scientific. Unrelated to this paper, he has served as a consultant for and has equity in Ablacon, Acutus Medical, Affera-Medtronic, Anumana, Apama Medical-Boston Scientific, APN Health, Append Medical, Aquaheart, Atacor, Autonomix, Axon Therapies, Backbeat, BioSig, CardiaCare, Cardiofocus, CardioNXT\/AFTx, Circa Scientific, CoRISMA, Corvia Medical, Dinova-Hangzhou DiNovA EP Technology, East End Medical, EPD-Philips, EP Frontiers, Field Medical, Focused Therapeutics, HRT, Intershunt, Javelin, Kardium, Laminar Medical, LuxMed, Medlumics, Neutrace, Nuvera-Biosense Webster, Oracle Health, Pulse Biosciences, Restore Medical, Sirona Medical, SoundCath and Valcare. Unrelated to this work, he has served as a consultant for Abbott, Adagio Medical, AtriAN, Biosense-Webster, BioTel Heart, Biotronik, Cairdac, Cardionomic, CoreMap, Fire1, Gore & Associates, Impulse Dynamics, Medtronic, Novartis, Novo Nordisk and Philips. Unrelated to this work, he has equity in Atraverse, DRS Vascular, Manual Surgical Sciences, Newpace, Nyra Medical, Surecor and Vizaramed. E.P.G. has served as a consultant to Boston Scientific, Biosense Webster and Adagio Medical; received lecture honoraria from Boston Scientific, Medtronic, Biosense Webster, Adagio Medical and Abbott; and received research grants from Abbott, Biosense Webster, Boston Scientific and Adagio Medical. S.E.M. has served as a consultant to Biosense Webster and Medtronic; received lecture honoraria from Medtronic, Biosense Webster and Abbott; and received research grants from Medtronic. C.P. has served as a consultant for Boston Scientific. K.A.E. has received honoraria and served as a consultant to Medtronic, Boston Scientific and Abbott. A.N. has served as a consultant for Abbott, Biotronik, Biosense Webster, Boston Scientific, Field Medical, iRhythm, Medtronic and Pulse Biosciences. J.W. has previously served on an advisory board for HeartcoR Solutions, currently consults for Heartbeam, Inc. and receives research support from Anumana, all unrelated to this work. H.C. has served as a consultant and\/or has received honoraria from Boston Scientific and Abbott. S.K.G. has served as a consultant for Boston Scientific, Abbott and Cordis. C.E.W. has served as an unpaid consultant to Boston Scientific, Abbott and Atricure; given unpaid lectures for Abbott and Atricure; and has equity in SoloPace and Pacenet. M.D. has served as a consultant for Boston Scientific. F.A.C. has served as a consultant to and performed research activities for Boston Scientific. D.B.D. has served as a consultant to Boston Scientific. E.R., M.D.M. and B.S. are employees and shareholders of Boston Scientific. M.M. has served as a consultant for Boston Scientific, Medtronic, Johnson & Johnson and Abbott and has equity and\/or stock options in NewPace Ltd. and EPD Solutions. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}